发明授权
- 专利标题： Modulation of glucagon receptor expression
- 专利标题（中）： 调节胰高血糖素受体表达
-
申请号： US13566642申请日： 2012-08-03
-
公开(公告)号： US08642753B2公开(公告)日： 2014-02-04
- 发明人: Susan M. Freier , Kenneth W. Dobie , Robert McKay , Sanjay Bhanot
- 申请人： Susan M. Freier , Kenneth W. Dobie , Robert McKay , Sanjay Bhanot
- 申请人地址： US CA Carlsbad
- 专利权人： Isis Pharmaceuticals, Inc.
- 当前专利权人： Isis Pharmaceuticals, Inc.
- 当前专利权人地址： US CA Carlsbad
- 代理机构： Isis Pharmaceuticals, Inc. Patent Dept.
- 主分类号： C07H21/04
- IPC分类号： C07H21/04
摘要：
Compounds, compositions and methods are provided for modulating the expression of glucagon receptor. The compositions comprise oligonucleotides, targeted to nucleic acid encoding glucagon receptor. Methods of using these compounds for modulation of glucagon receptor expression and for diagnosis and treatment of disease associated with expression of glucagon receptor are provided.
公开/授权文献
- US20120295958A1 MODULATION OF GLUCAGON RECEPTOR EXPRESSION 公开/授权日：2012-11-22
信息查询
